TAM
PACB icon

Tocqueville Asset Management’s Pacific Biosciences PACB Stock Holding History

Tocqueville Asset Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-25,000
Closed -$95K – 829
2016
Q4 		$95K Hold
25,000
– – ﹤0.01% 789
2016
Q3 		$224K Hold
25,000
– – ﹤0.01% 767
2016
Q2 		$176K Buy
25,000
+700
+3% +$6.39K ﹤0.01% 798
2016
Q1 		$207K Buy
+24,300
New +$239K ﹤0.01% 800

Other funds holding PACB

Credit Agricole
Credit Agricole Montrouge Cedex, France $49.3B AUM 36.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Tocqueville Asset Management's PACB Position: Q1 2017 in Review

Tocqueville Asset Management sold out of Pacific Biosciences (PACB) in Q1 2017, closing a stake of 25,000 shares — an estimated $95K sold.

Tocqueville Asset Management first reported a position in PACB in Q1 2016 and held it in 4 quarters. The position peaked at $224K in Q3 2016. 106 funds tracked by Wall St. Rank hold PACB as of Q1 2017.

  • Tocqueville Asset Management reported no remaining Pacific Biosciences position as of Q1 2017 after selling out during the quarter.
  • Tocqueville Asset Management sold 25,000 Pacific Biosciences shares in Q1 2017, an estimated $95K.
  • Tocqueville Asset Management first reported a position in Pacific Biosciences in Q1 2016 and held it in 4 quarters.
  • Tocqueville Asset Management's Pacific Biosciences position peaked at $224K in Q3 2016.
  • 106 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2017.

Based on Tocqueville Asset Management's 13F filing for Q1 2017, filed 28 Apr 2017.